Cleared Traditional

K935393 - CHLAMYDIA MICROPLATE EIA, CHLAMYDIA MICROPLAE EIA BLOCKING ASSAY (FDA 510(k) Clearance)

Sep 1994
Decision
316d
Days
Class 1
Risk

K935393 is an FDA 510(k) clearance for the CHLAMYDIA MICROPLATE EIA, CHLAMYDIA MICROPLAE EIA BLOCKING ASSAY. This device is classified as a Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group) (Class I - General Controls, product code LJC).

Submitted by Bio-Rad Laboratories, Inc. (Chaska, US). The FDA issued a Cleared decision on September 20, 1994, 316 days after receiving the submission on November 8, 1993.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3120.

Submission Details

510(k) Number K935393 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 08, 1993
Decision Date September 20, 1994
Days to Decision 316 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LJC — Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3120